keyword
https://read.qxmd.com/read/38646986/ultrasound-and-cytopathological-characteristics-of-thyroid-tumours-of-uncertain-malignant-potential-from-diagnosis-to-treatment
#1
JOURNAL ARTICLE
Agnieszka Żyłka, Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Maciej Jędrzejczyk, Piotr Góralski, Jacek Gałczyński, Elwira Bakuła-Zalewska, Marek Dedecjus
INTRODUCTION: The latest World Health Organization (WHO) classification from 2022 distinguishes the division of low-risk thyroid neoplasms such as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), follicular tumour of uncertain malignant potential (FT-UMP), and well-differentiated tumour of uncertain malignant potential (WDT-UMP). The final diagnosis is made postoperatively according to histopathologic results. The aim of the study was the assessment of ultrasonographic and cytopathological features of borderline lesions to predict low-risk tumours preoperatively and plan the optimal treatment for that group of patients...
April 22, 2024: Endokrynologia Polska
https://read.qxmd.com/read/38646957/metabolite-signature-of-human-malignant-thyroid-tissue-a-systematic-review-and-meta-analysis
#2
REVIEW
S Adeleh Razavi, Babak Khorsand, Pouya Salehipour, Mehdi Hedayati
BACKGROUND: Thyroid cancer (TC) is the predominant malignancy within the endocrine system. However, the standard method for TC diagnosis lacks the capability to identify the pathological condition of all thyroid lesions. The metabolomics approach has the potential to manage this problem by identifying differential metabolites. AIMS: This study conducted a systematic review and meta-analysis of the NMR-based metabolomics studies in order to identify significant altered metabolites associated with TC...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38646500/tumor%C3%A2-suppressive-effects-of-smad%C3%A2-ubiquitination-regulator-2-in-papillary-thyroid-carcinoma
#3
JOURNAL ARTICLE
Guirong Luo, Liting Zhang, Lihong Zhang, Wenyi Wu, Jianqing Lin, Haihong Shi, Yihuang Yu, Weigang Qiu, Jinyan Chen, Hansen Ding, Xinyao Chen
Smad-ubiquitination regulator 2 (SMURF2) functions as a homolog of E6AP carboxyl terminus-type E3 ubiquitin ligase to regulate cell cycle progression and tumor growth factor expression. SMURF2 has been revealed to function as a tumor suppressor in a number of cancers; however, its function in papillary thyroid carcinoma (PTC) remains largely unknown. Therefore, the aim of the present study was to investigate the function of SMURF2 in PTC. Reverse transcription-quantitative PCR and western blotting were used to detect cellular expression of SMURF2 in vitro ...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646445/window-of-opportunity-with-pd1-blockade-before-chemoradiotherapy-for-an-advanced-stage-clear-cell-carcinoma-of-the-cervix
#4
Marie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, Jean-Christophe Tille, Patrick Petignat, Manuela Undurraga, S Intidhar Labidi-Galy
Clear cell carcinoma is a rare and very aggressive subset of cervical cancer, with poor outcome if diagnosed at advanced stage. There are few data available on the optimal management of this histotype, and treatment recommendations that include surgery and chemoradiotherapy, are essentially based on those for squamous cell carcinoma. Here we report the case of a young patient newly diagnosed with advanced stage (FIGO IIB) clear cell carcinoma of the uterine cervix who received a window of opportunity one injection of nivolumab followed by standard chemoradiotherapy...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38646429/optimal-surgical-population-for-cervical-lymph-node-dissection-in-ptc
#5
JOURNAL ARTICLE
Yongkun Wang, Zhen Wu, Jinqiang Yan, Yumin Yao, Lin Han
OBJECTIVE: There is still controversy about whether cervical lymph node dissection should be performed in surgical treatment of PTC. Based on the data of thyroid cancer patients from Liaocheng People's Hospital from 2015 to 2018, this study focused on appropriate indications for cervical lymph node dissection surgery. METHODS: The clinical and pathological data of patients with initial treatment of PTC in thyroid surgery department from 2015 to 2018 were collected...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38646274/long-term-survival-of-a-patient-with-anaplastic-thyroid-carcinoma-treated-with-hypofractionated-radiotherapy-a-case-report
#6
Mitsuki Tanaka, Yoshiomi Hatayama, Hideo Kawaguchi, Ichitaro Fujioka, Masahiro Aoki
Anaplastic thyroid carcinoma, a rare type of primary thyroid cancer, is one of the most aggressive neoplasms with a poor prognosis. Many cases are in the advanced stage at the time of the initial visit, and curative treatment is impossible. Because of the highly radioresistant nature of anaplastic thyroid carcinoma, this condition cannot be properly controlled with conventional radiotherapy. Herein, we report the case of a patient with anaplastic thyroid carcinoma who underwent hypofractionated radiotherapy, attained a complete response, and is still alive more than 10 years after treatment with no evidence of disease...
March 2024: Curēus
https://read.qxmd.com/read/38644759/prevalence-and-impact-of-endocrine-disorders-in-advanced-metastatic-cancer-patients-undergoing-cancer-directed-therapy-a-prospective-observational-study
#7
JOURNAL ARTICLE
Gaurav Karna, Amit Sehrawat, Saurabh Karna, Ravi Kant, Deepak Sundriyal, Summi Karn, Dipesh Jha
BACKGROUND: Noncommunicable diseases (NCDs) contribute significantly to global morbidity and mortality, with cancer being one of the leading causes. In this prospective observational study, we aimed to investigate the prevalence and impact of endocrine disorders, specifically diabetes and thyroid dysfunction, in patients with advanced metastatic cancer undergoing cancer-directed therapy. METHODS: Over 15 months, we recruited 100 histologically proven advanced metastatic cancer patients from the Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, and conducted institutional-based prospective observational study...
April 2024: Cancer reports
https://read.qxmd.com/read/38644545/stepwise-analysis-of-thyroid-diagnostic-modalities-with-genomic-imprinting-detection
#8
JOURNAL ARTICLE
Wanting Yang, Ming Yin, Jiehong Zhou, Yun Zhu, Beibei Ye, Hui Shi, Bingjie Zhang, Can Yue, Yifeng Zhang, Hongxun Wu, Haohao Li, Xuliang Xia, Shufang Yang, Buyun Ma
BACKGROUND: The current preoperative malignancy risk evaluation for thyroid nodules involves stepwise diagnostic modalities including ultrasonography, thyroid function serology and fine-needle aspiration (FNA) cytopathology, respectively. We aimed to substantiate the stepwise contributions of each diagnostic step and additionally investigate the diagnostic significance of quantitative chromogenic imprinted gene in-situ hybridization (QCIGISH)-an adjunctive molecular test based on epigenetic imprinting alterations...
April 12, 2024: Chinese Clinical Oncology
https://read.qxmd.com/read/38643022/avoiding-needless-nephrectomy-what-is-the-role-of-small-renal-mass-biopsy-in-2024
#9
REVIEW
Bruce Gao, Antonio R H Gorgen, Rohit Bhatt, Zachary E Tano, Kalon L Morgan, Kelvin Vo, Sina Soltanzadeh Zarandi, Sohrab N Ali, Pengbo Jiang, Roshan M Patel, Ralph V Clayman, Jaime Landman
Current guidelines do not mandate routine preoperative renal mass biopsy (RMB) for small renal masses (SRMs), which results in a considerable rate (18%-26%) of needless nephrectomy/partial nephrectomy for benign renal tumors. In light of this ongoing practice, a narrative review was conducted to examine the role of routine RMB for SRM. First, arguments justifying the current non-biopsy approach to SRM are critically reviewed and contested. Second, as a standalone procedure, RMB is critically assessed; RMB was found to have higher sensitivity, specificity, and an equal or lower complication rate when compared with other commonly preoperatively biopsied solid organ tumors (e...
April 19, 2024: Urologic Oncology
https://read.qxmd.com/read/38638336/cervicomediastinal-hematoma-atypical-presentation-of-a-parathyroid-carcinoma
#10
Martina Cicia, Giampaolo Papi, Alfredo Scillitani, Stefania Corrado, Pietro Locantore, Alfredo Pontecorvi
Parathyroid carcinoma (PC) is a rare endocrine neoplasm that typically presents with osteopenia/osteoporosis, nephrolithiasis, asthenia, and neuropsychiatric symptoms. We describe the case of a 48-year-old woman, presenting with a large painful hematoma in the cervicomediastinal area. The neck ultrasound (US) demonstrated a solid lesion measuring 40 × 80 × 55 mm, markedly hypoechoic, which extended from the right thyroid lobe to the mediastinum. The blood tests showed elevated serum calcium and parathyroid hormone (PTH) concentrations, consistent with hypercalcemic primary hyperparathyroidism...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38634043/keap1-nrf2-pathway-a-key-mechanism-in-the-occurrence-and-development-of-cancer
#11
REVIEW
Feilong Chen, Mei Xiao, Shaofan Hu, Meng Wang
The Keap1-Nrf2 signaling pathway is a major regulator of the cytoprotective response, participating in endogenous and exogenous stress caused by ROS (reactive oxygen species). Nrf2 is the core of this pathway. We summarized the literature on Keap1-Nrf2 signaling pathway and summarized the following three aspects: structure, function pathway, and cancer and clinical application status. This signaling pathway is similar to a double-edged sword: on the one hand, Nrf2 activity can protect cells from oxidative and electrophilic stress; on the other hand, increasing Nrf2 activity can enhance the survival and proliferation of cancer cells...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38630091/editorial-comment-beyond-the-scalpel-embracing-thermal-ablation-for-thyroid-nodules-in-interventional-radiology
#12
COMMENT
Roger Tomihama
No abstract text is available yet for this article.
April 17, 2024: AJR. American Journal of Roentgenology
https://read.qxmd.com/read/38622568/correlation-between-socioeconomic-indices-and-epidemiological-indices-of-thyroid-cancer-from-1990-to-2019-year-a-global-ecologic-study
#13
JOURNAL ARTICLE
Zahra Maleki, Jafar Hassanzadeh, Haleh Ghaem
BACKGROUND: The incidence of thyroid cancer as the most common type of endocrine gland malignancy has risen more significantly than any malignancies in recent years. Estimated new cases of thyroid cancer in the United States in 2024 were 12,500 and 31,520 for men and women, respectively, and estimated deaths were 1,180 for women and 990 for men. Indices of socio-economic have been commonly used to measure the development of countries. Therefore, this study aimed to examine the correlation between indices of socioeconomic status and epidemiological indices of thyroid cancer throughout the world...
April 15, 2024: BMC Cancer
https://read.qxmd.com/read/38617188/serum-biochemical-markers-for-medullary-thyroid-carcinoma-an-update
#14
REVIEW
Shuzhou Liu, Hao Zhao, Xiaoyi Li
INTRODUCTION: Medullary thyroid carcinoma (MTC), a rare malignancy, requires early diagnosis for optimal patient outcomes. An important aspect of MTC diagnosis is the assessment of serum biomarkers. This review aimed to evaluate the use of serum biomarkers in the diagnosis, prognosis, and follow-up of MTC. METHODS: A thorough search of PubMed covering 1975 to 2022 was conducted to identify English-language articles on MTC serum biomarkers. RESULTS: The review revealed that calcitonin (Ctn) and carcinoembryonic antigen (CEA) remain the most important serum biomarkers for MTC diagnosis and management...
2024: Cancer Management and Research
https://read.qxmd.com/read/38614530/multiple-and-hereditary-renal-tumors-a-review-for-radiologists
#15
JOURNAL ARTICLE
M Á Corral de la Calle, J Encinas de la Iglesia, G C Fernández Pérez, A Fraino, M Repollés Cobaleda
80% of renal carcinomas (RC) are diagnosed incidentally by imaging. 2-4% of "sporadic" multifocality and 5-8% of hereditary syndromes are accepted, probably with underestimation. Multifocality, young age, familiar history, syndromic data, and certain histologies lead to suspicion of hereditary syndrome. Each tumor must be studied individually, with a multidisciplinary evaluation of the patient. Nephron-sparing therapeutic strategies and a radioprotective diagnostic approach are recommended. Relevant data for the radiologist in major RC hereditary syndromes are presented: von-Hippel-Lindau, Chromosome-3 translocation, BRCA-associated protein-1 mutation, RC associated with succinate dehydrogenase deficiency, PTEN, hereditary papillary RC, Papillary thyroid cancer- Papillary RC, Hereditary leiomyomatosis and RC, Birt-Hogg-Dubé, Tuberous sclerosis complex, Lynch, Xp11...
2024: Radiología
https://read.qxmd.com/read/38611106/exploring-the-link-between-bmi-and-aggressive-histopathological-subtypes-in-differentiated-thyroid-carcinoma-insights-from-a-multicentre-retrospective-study
#16
JOURNAL ARTICLE
Giacomo Di Filippo, Gian Luigi Canu, Giovanni Lazzari, Dorin Serbusca, Eleonora Morelli, Paolo Brazzarola, Leonardo Rossi, Benard Gjeloshi, Mariangela Caradonna, George Kotsovolis, Ioannis Pliakos, Efthymios Poulios, Theodosios Papavramidis, Federico Cappellacci, Pier Francesco Nocini, Pietro Giorgio Calò, Gabriele Materazzi, Fabio Medas
Obesity's role in thyroid cancer development is still debated, as well as its association with aggressive histopathological subtypes (AHSs). To clarify the link between Body Mass Index (BMI) and AHS of differentiated thyroid carcinoma (DTC), we evaluated patients who underwent thyroidectomy for DTC from 2020 to 2022 at four European referral centres for endocrine surgery. Based on BMI, patients were classified as normal-underweight, overweight, or obese. AHSs were defined according to 2022 WHO guidelines. Among 3868 patients included, 34...
April 7, 2024: Cancers
https://read.qxmd.com/read/38611079/advances-in-the-development-of-positron-emission-tomography-tracers-for-improved-detection-of-differentiated-thyroid-cancer
#17
REVIEW
Hannelore Iris Coerts, Bart de Keizer, Frederik Anton Verburg
Thyroid cancer poses a significant challenge in clinical management, necessitating precise diagnostic tools and treatment strategies for optimal patient outcomes. This review explores the evolving field of radiotracers in the diagnosis and management of thyroid cancer, focusing on prostate-specific membrane antigen (PSMA)-based radiotracers, fibroblast activation protein inhibitor (FAPI)-based radiotracers, Arg-Gly-Asp (RGD)-based radiotracers, and 18 F-tetrafluoroborate (18 F-TFB). PSMA-based radiotracers, initially developed for prostate cancer imaging, have shown promise in detecting thyroid cancer lesions; however, their detection rate is lower than 18 F-FDG PET/CT...
April 2, 2024: Cancers
https://read.qxmd.com/read/38611060/increased-pituitary-fluorine-18-fluorodeoxyglucose-uptake-in-patients-with-differentiated-thyroid-cancer-in-hypothyroidism-versus-under-recombinant-human-thyroid-stimulating-hormone-stimulation
#18
JOURNAL ARTICLE
Xinyi Shi, Ilaria Giordani, Marie Nicod Lalonde, Gerasimos P Sykiotis
BACKGROUND: 18 F-FDG PET/CT is performed for the assessment of radioactive iodine non-avid disease in patients with DTC. In patients prepared by THW, increased pituitary uptake of 18 F-FDG in the absence of pituitary disease may reflect the physiological activation of pituitary thyrotroph cells by hypothyroidism. This study aimed to compare pituitary 18 F-FDG uptake in patients with DTC under THW vs. rhTSH stimulation. METHODS: A total of 57 patients with DTC undergoing 18 F-FDG PET/CT (40 under THW and 17 under rhTSH stimulation) were retrospectively analyzed...
March 31, 2024: Cancers
https://read.qxmd.com/read/38611018/early-serum-markers-for-immune-checkpoint-inhibitor-induced-hypophysitis-in-melanoma-patients
#19
JOURNAL ARTICLE
Fouad Mitri, Devayani Machiraju, Christina Naoum, Jessica C Hassel
BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown promising anti-tumor activities and are widely used for the treatment of advanced cancers. However, they may lead to immune-related adverse events (irAEs) and some of them, such as hypophysitis, can be life-threatening. Here, early diagnosis is critical. METHODS: We retrospectively analyzed 40 melanoma patients who developed hypophysitis during ICI treatment with either ipilimumab and/or anti-PD1 therapy and compared them to 40 control patients who did not develop hypophysitis during the ICI treatment, matched for age, gender, type of immunotherapy, and stage...
March 29, 2024: Cancers
https://read.qxmd.com/read/38610938/sex-specific-expression-of-histone-lysine-demethylases-kdms-in-thyroid-cancer
#20
JOURNAL ARTICLE
Leila Shobab, Hui Zheng, Kirk Jensen, Maria Cecilia Mendonca-Torres, Matthew McCoy, Victoria Hoperia, Jennifer Rosen, Leonard Wartofsky, Kenneth Burman, Vasyl Vasko
BACKGROUND: The incidence of thyroid cancer in women is 3-4-fold higher than in men. To characterize sex-specific molecular alterations in thyroid cancer, we examined the expression of sex-biased genes in normal thyroids and thyroid tumors. METHODS: Ingenuity pathways analysis was used to define sex-biased gene networks using data from the Cancer Genome Atlas (TCGA). Confirmatory studies were performed through the analysis of histone lysine demethylases (KDMs) expression by real-time PCR and immunostaining...
March 23, 2024: Cancers
keyword
keyword
55031
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.